Top advances in lymphoma for 2021
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34483
Abstract: Chimeric antigen receptor (CAR) T‐cell therapy, antibody–drug conjugates, bispecific T‐cell redirectors, and agents targeting tonic B‐cell receptor signaling have altered the paradigm for three of the most common lymphomas in the year 2021. For diffuse… read more here.
Keywords: cell; top advances; lymphoma; advances lymphoma ... See more keywords